ATE267012T1 - Tetrahydro-beta carbolinverbindungen - Google Patents

Tetrahydro-beta carbolinverbindungen

Info

Publication number
ATE267012T1
ATE267012T1 AT97916854T AT97916854T ATE267012T1 AT E267012 T1 ATE267012 T1 AT E267012T1 AT 97916854 T AT97916854 T AT 97916854T AT 97916854 T AT97916854 T AT 97916854T AT E267012 T1 ATE267012 T1 AT E267012T1
Authority
AT
Austria
Prior art keywords
tetrahydro
compounds
beta
carboline compounds
beta carboline
Prior art date
Application number
AT97916854T
Other languages
English (en)
Inventor
James E Audia
David L G Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE267012T1 publication Critical patent/ATE267012T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT97916854T 1996-03-25 1997-03-24 Tetrahydro-beta carbolinverbindungen ATE267012T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1411996P 1996-03-25 1996-03-25
PCT/US1997/004473 WO1997035578A1 (en) 1996-03-25 1997-03-24 Tetrahydro-beta-carboline compounds

Publications (1)

Publication Number Publication Date
ATE267012T1 true ATE267012T1 (de) 2004-06-15

Family

ID=21763645

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916854T ATE267012T1 (de) 1996-03-25 1997-03-24 Tetrahydro-beta carbolinverbindungen

Country Status (20)

Country Link
US (1) US5886004A (de)
EP (1) EP0942722B1 (de)
JP (1) JP2001509130A (de)
KR (1) KR20000004963A (de)
CN (1) CN1225584A (de)
AT (1) ATE267012T1 (de)
AU (1) AU714024B2 (de)
BR (1) BR9708347A (de)
CA (1) CA2248874A1 (de)
CZ (1) CZ298098A3 (de)
DE (1) DE69729211T2 (de)
EA (1) EA199800867A1 (de)
ES (1) ES2221049T3 (de)
IL (1) IL126062A0 (de)
NO (1) NO984445L (de)
NZ (1) NZ331827A (de)
PL (1) PL329212A1 (de)
TR (1) TR199801910T2 (de)
WO (1) WO1997035578A1 (de)
YU (1) YU41998A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2000069437A1 (en) 1999-05-18 2000-11-23 Synaptic Pharmaceutical Corporation Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
US6444477B1 (en) * 2000-11-28 2002-09-03 Pharmagene Laboratories Limited Assay method for detecting 5-HT2B antagonists
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2005079845A1 (ja) * 2004-02-20 2005-09-01 Astellas Pharma Inc. 片頭痛予防薬
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7645778B2 (en) * 2005-01-19 2010-01-12 Bristol-Myers Squibb Company Heteroaryl compounds as P2Y1 receptor inhibitors
TW200638926A (en) * 2005-02-08 2006-11-16 Astellas Pharma Inc A therapeutic agent for irritable bowel disease
US7816382B2 (en) 2005-06-27 2010-10-19 Bristol-Myers Squibb Company Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
ATE485269T1 (de) * 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
AR056867A1 (es) * 2005-06-27 2007-10-31 Bristol Myers Squibb Co Antagonistas heterociclicos n- enlazados del receptor de p2y1 utiles en el tratamiento de condiciones tromboticas. composiciones farmaceuticas.
WO2007002634A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US8076348B2 (en) * 2005-08-08 2011-12-13 Astellas Pharma Inc. Acylguanidine derivative or salt thereof
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2012051502A1 (en) 2010-10-14 2012-04-19 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500431A (en) * 1993-04-14 1996-03-19 Eli Lilly And Company Tetrahydro-β-carbolines
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
CZ264996A3 (cs) * 1994-03-11 1998-01-14 Eli Lilly And Company Použití sloučenin, které jsou aktivní na 5HT2B receptor
CN1218368A (zh) * 1996-03-15 1999-06-02 伊莱利利公司 治疗感冒或过敏性鼻炎的方法
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings

Also Published As

Publication number Publication date
EP0942722B1 (de) 2004-05-19
DE69729211D1 (en) 2004-06-24
EA199800867A1 (ru) 1999-02-25
CA2248874A1 (en) 1997-10-02
EP0942722A1 (de) 1999-09-22
IL126062A0 (en) 1999-05-09
US5886004A (en) 1999-03-23
NO984445D0 (no) 1998-09-24
JP2001509130A (ja) 2001-07-10
CZ298098A3 (cs) 1999-02-17
AU2536197A (en) 1997-10-17
DE69729211T2 (de) 2005-05-04
YU41998A (sh) 1999-07-28
CN1225584A (zh) 1999-08-11
BR9708347A (pt) 1999-08-03
NO984445L (no) 1998-11-20
ES2221049T3 (es) 2004-12-16
KR20000004963A (ko) 2000-01-25
EP0942722A4 (de) 2002-06-05
AU714024B2 (en) 1999-12-16
WO1997035578A1 (en) 1997-10-02
NZ331827A (en) 2000-02-28
TR199801910T2 (xx) 1998-12-21
PL329212A1 (en) 1999-03-15

Similar Documents

Publication Publication Date Title
ATE267012T1 (de) Tetrahydro-beta carbolinverbindungen
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
ES2168650T3 (es) Compuestos y metodos moduladores de receptores de androgenos.
NO990985D0 (no) Katalytisk blanding egnet for Fischer-Tropsch-prosessen
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
IL132249A0 (en) Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
HU9801711D0 (en) Use of substituted imidazolidin-2,4-dion compounds as analgetic
BG103548A (en) Vitronectine receptor antagonists
PL344475A1 (en) Bridged indenopyrrolocarbazoles
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
NO964348D0 (no) CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
IL128186A0 (en) Intermediates for the preparation of 2-imidazoline-5-ones
EP0971885A4 (de) Verfahren zur herstellung von indan-ähnlichen verbindungen
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
IT1302693B1 (it) Procedimento per il risanamento degli argini
DK0593285T3 (da) Mellemprodukter og fremgangsmåder dertil til fremstilling af 5,6-dihydropyrrolo-(2,3-d)pyrimidiner
TR200001329T2 (tr) Pirrolo (3,2-b) piridin için yöntemler ve ara bileşikler
MY127539A (en) Bridged indenopyrrolocarbazoles
UY24621A1 (es) Nuevos compuestos
MX9707832A (es) 1-fenil-3-pirazolcarboxilamidas que actuan sobre los receptores de neurotensina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties